These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18566754)

  • 1. CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Choi S; Baldini C; Konstantinidou G; Pandolfi PP
    Mol Cell Biochem; 2008 Sep; 316(1-2):149-54. PubMed ID: 18566754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CK2 and PML: regulating the regulator.
    Lallemand-Breitenbach V; de Thé H
    Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer.
    Chatterjee A; Chatterjee U; Ghosh MK
    Cell Death Dis; 2013 Mar; 4(3):e543. PubMed ID: 23492774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.
    Sivachandran N; Cao JY; Frappier L
    J Virol; 2010 Nov; 84(21):11113-23. PubMed ID: 20719947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
    Rabellino A; Carter B; Konstantinidou G; Wu SY; Rimessi A; Byers LA; Heymach JV; Girard L; Chiang CM; Teruya-Feldstein J; Scaglioni PP
    Cancer Res; 2012 May; 72(9):2275-84. PubMed ID: 22406621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.
    Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK
    Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
    Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
    Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradation.
    Sewatanon J; Ling PD
    Virology; 2013 Jun; 440(2):140-9. PubMed ID: 23541081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
    Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
    Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.
    Gresko E; Ritterhoff S; Sevilla-Perez J; Roscic A; Fröbius K; Kotevic I; Vichalkovski A; Hess D; Hemmings BA; Schmitz ML
    Oncogene; 2009 Feb; 28(5):698-708. PubMed ID: 19015637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome.
    Fanelli M; Fantozzi A; De Luca P; Caprodossi S; Matsuzawa S; Lazar MA; Pelicci PG; Minucci S
    J Biol Chem; 2004 Feb; 279(7):5374-9. PubMed ID: 14645235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
    Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
    J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.
    Hung MS; Lin YC; Mao JH; Kim IJ; Xu Z; Yang CT; Jablons DM; You L
    PLoS One; 2010 Jul; 5(7):e11418. PubMed ID: 20625391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemically induced degradation of CK2 by proteolysis targeting chimeras based on a ubiquitin-proteasome pathway.
    Chen H; Chen F; Liu N; Wang X; Gou S
    Bioorg Chem; 2018 Dec; 81():536-544. PubMed ID: 30245235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
    Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
    J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of PML ubiquitination in human malignancies.
    Chen RH; Lee YR; Yuan WC
    J Biomed Sci; 2012 Aug; 19(1):81. PubMed ID: 22935031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.
    Kalathur M; Toso A; Chen J; Revandkar A; Danzer-Baltzer C; Guccini I; Alajati A; Sarti M; Pinton S; Brambilla L; Di Mitri D; Carbone G; Garcia-Escudero R; Padova A; Magnoni L; Tarditi A; Maccari L; Malusa F; Kalathur RK; A Pinna L; Cozza G; Ruzzene M; Delaleu N; Catapano CV; Frew IJ; Alimonti A
    Nat Commun; 2015 Jun; 6():7227. PubMed ID: 26085373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.